Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug interactions with clinafloxacin.

E J Randinitis1, C W Alvey, J R Koup

  • 1Clinical Pharmacokinetics and Pharmacodynamics Department, Pfizer Global Research and Development, Ann Arbor, Michigan 48105, USA. Edward.Randinitis@pfizer.com

Antimicrobial Agents and Chemotherapy
|August 15, 2001
PubMed
Summary

Clinafloxacin significantly impacts drug metabolism, reducing clearance for theophylline and caffeine, and altering warfarin levels. It also slightly decreases phenytoin clearance, highlighting potential drug interaction risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ISIS Penning source extraction studies reveal the 3-dimensional Child-Langmuir effect.

The Review of scientific instruments·2020
Same author

Gender and cultural bias in student evaluations: Why representation matters.

PloS one·2019
Same author

Recent H<sup>-</sup> diagnostics, plasma simulations, and 2X scaled Penning ion source developments at the Rutherford Appleton Laboratory.

The Review of scientific instruments·2018
Same author

[Risk factors for the development of rotator cuff tears in individuals with paraplegia : A cross-sectional study].

Der Orthopade·2018
Same author

The effect of long-term bisphosphonate therapy on trabecular bone strength and microcrack density.

Bone & joint research·2017
Same author

Spinal cord ability ruler: an interval scale to measure volitional performance after spinal cord injury.

Spinal cord·2017

Area of Science:

  • Pharmacology
  • Drug Metabolism
  • Drug Interactions

Background:

  • Fluoroquinolone antibiotics, like clinafloxacin, can inhibit cytochrome P450 enzymes.
  • This inhibition can lead to significant drug-drug interactions when co-administered with other medications.

Purpose of the Study:

  • To investigate the pharmacokinetic interactions between clinafloxacin and theophylline, caffeine, warfarin, and phenytoin.
  • To assess the impact of phenytoin on clinafloxacin pharmacokinetics.

Main Methods:

  • Pharmacokinetic studies involving the administration of clinafloxacin with theophylline, caffeine, warfarin, and phenytoin.
  • Analysis of plasma concentrations and clearance rates of the involved drugs.

Main Results:

Related Experiment Videos

  • Clinafloxacin (200-400 mg) reduced theophylline clearance by 50-70% and caffeine clearance by 84%.
  • (R)-warfarin plasma concentrations increased by 32% during clinafloxacin treatment; (S)-warfarin concentrations were unchanged.
  • Phenytoin clearance was reduced by 15% during clinafloxacin administration, while clinafloxacin pharmacokinetics were unaffected by phenytoin.

Conclusions:

  • Clinafloxacin significantly alters the pharmacokinetics of theophylline, caffeine, and warfarin, indicating a high potential for drug interactions.
  • Clinafloxacin may also affect phenytoin clearance, and gut flora changes might contribute to observed pharmacodynamic effects.